BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/10/2022 9:43:36 AM | Browse: 462 | Download: 1035
 |
Received |
|
2021-03-08 22:47 |
|
Peer-Review Started |
|
2021-03-08 22:53 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-29 17:05 |
|
Revised |
|
2021-04-14 02:19 |
|
Second Decision |
|
2022-04-15 02:03 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-04-16 14:36 |
|
Articles in Press |
|
2022-04-16 14:36 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-04-27 12:25 |
|
Publish the Manuscript Online |
|
2022-05-10 09:43 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Imaad Said, Hassan Ahad and Adnan Said |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Adnan Said, FAASLD, MD, MS, Associate Professor, Division of Gastroenterology and Hepatology, Department of Medicine, William S. Middleton VAMC, University of Wisconsin School of Medicine and Public Health, 4223 MFCB, 1685 Highland Avenue, Madison, WI 53705, United States. axs@medicine.wisc.edu |
| Key Words |
Microbiome; Gut microbiome; Hepatocellular carcinoma; Nonalcoholic fatty liver disease; Pathophysiology; Treatment |
| Core Tip |
The gut microbiome is intimately linked to nonalcoholic fatty liver disease, cirrhosis and hepatocellular carcinoma. The breakdown of the intestinal barrier in liver disease, innate immune system stimulation and bile acid profile changes are increasingly found in association with these diseases. Manipulation of the microbiome by diet, probiotics, prebiotics and other agents is a promising area of investigation. |
| Publish Date |
2022-05-10 09:43 |
| Citation |
Said I, Ahad H, Said A. Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics. World J Gastrointest Oncol 2022; 14(5): 947-958 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i5/947.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i5.947 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
